In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant acinetobacter baumannii, including colistin- or tigecycline-resistant isolates

Journal of Medical Microbiology

Volumn 61, Issue 3, 2012, Pages 353-360

  Peck, Kyong Ran ^a   Kim, Min Ja ^b   Choi, Ji Young ^a   Kim, Hong Sun ^a   Kang, Cheol In ^a   Cho, Yong Kyun ^c   Park, Dae Won ^d   Lee, Hee Joo ^e   Lee, Mi Suk ^e   Ko, Kwan Soo ^a,f  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Kyung Hee University Hospital   (South Korea)

^f Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; IMIPENEM; RIFAMPICIN; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); DRUG EFFICACY; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MINOCYCLINE; TIME FACTORS;

EID: 84863115478     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.036939-0     Document Type: Article

References (31)

1. Capone, A., D'Arezzo, S., Visca, P. & Petrosillo, N. (2008). In vitro activity of tigecycline against multidrug-resistant Acinetobacter bauman-nii. J Antimicrob Chemother 62, 422-423.
2. CLSI (2010). Performance Standards for Antimicrobial Susceptibility Testing, 20th informational supplement, M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute.
3. Dijkshoorn, L., Nemec, A. & Seifert, H. (2007). An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5, 939-951.
4. Doi, Y., Husain, S., Potoski, B. A., McCurry, K. R. & Paterson, D. L. (2009). Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis 15, 980-982.
5. Eliopoulos, G. M. & Moellering, R. C. (1996). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 4th edn. Edited by V. Lorian. Baltimore, MA: Williams & Wilkins.
6. Falagas, M. E., Bliziotis, I. A. & Siempos, I. I. (2006). Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 10, R48.
7. Gordon, N. C., Png, K. & Wareham, D. W. (2010). Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 54, 5316-5322.
8. Hawley, J. S., Murray, C. K. & Jorgensen, J. H. (2008). Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother 52, 351-352.
9. Hornsey, M. & Wareham, D. W. (2011). In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob Agents Chemother 55, 3534-3537.
10. Kim, C. K., Lee, Y., Lee, H., Woo, G. J., Song, W., Kim, M. N., Lee, W. G., Jeong, S. H., Lee, K. & Chong, Y. (2010). Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis 68, 432-438.
11. Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E. & Liolios, L. (2006a). Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 50, 2946- 2950.
12. Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R. & Paterson, D. L. (2006b). Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 6, 589-601.
13. Moland, E. S., Craft, D. W., Hong, S. G., Kim, S. Y., Hachmeister, L., Sayed, S. D. & Thomson, K. S. (2008). In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy. Antimicrob Agents Chemother 52, 2940-2942.
14. Munoz-Price, L. S. & Weinstein, R. A. (2008). Acinetobacter infection. N Engl J Med 358, 1271-1281.
15. Owen, R. J., Li, J., Nation, R. L. & Spelman, D. (2007). In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 59, 473-477.
16. Pachón-Ibánez, M. E., Fernández-Cuenca, F., Docobo-Pérez, F., Pachón J. & Pascual, A. (2006). Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. J Antimicrob Chemother 58, 689-692.
17. Pankey, G. A. & Ashcraft, D. S. (2009). The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assay. Diagn Microbiol Infect Dis 63, 228-232.
18. Park, Y. K., Jung, S. I., Park, K. H., Cheong, H. S., Peck, K. R., Song, J. H. & Ko, K. S. (2009a). Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn Microbiol Infect Dis 64, 43-51.
19. Park, Y. K., Choi, J. Y., Song, J. H. & Ko, K. S. (2009b). In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea. Int J Antimicrob Agents 33, 289-290.
20. Park, Y. K., Peck, K. R., Cheong, H. S., Chung, D. R., Song, J. H. & Ko, K. S. (2009c). Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea. Emerg Infect Dis 15, 1325-1327.
21. Park, Y. K., Choi, J. Y., Jung, S. I., Park, K. H., Lee, H., Jung, D. S., Heo, S. T., Kim, S. W., Chang, H. H. & other authors (2009d). Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals. Diagn Microbiol Infect Dis 64, 389-395.
22. Peleg, A. Y., Potoski, B. A., Rea, R., Adams, J., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V. & Paterson, D. L. (2007). Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother 59, 128-131.
23. Peleg, A. Y., Seifert, H. & Paterson, D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21, 538-582.
24. Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N. & Bonomo, R. A. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51, 3471-3484.
25. Petersen, P. J., Labthavikul, P., Jones, C. H. & Bradford, P. A. (2006). In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 57, 573-576.
26. Scheetz, M. H., Qi, C., Warren, J. R., Postelnick, M. J., Zembower, T., Obias, A. & Noskin, G. A. (2007). In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii. Anti-microb Agents Chemother 51, 1621-1626.
27. Song, J. Y., Kee, S. Y., Hwang, I. S., Seo, Y. B., Jeong, H. W., Kim, W. J. & Cheong, H. J. (2007). In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 60, 317-322.
28. Sopirala, M. M., Mangino, J. E., Gebreyes, W. A., Biller, B., Bannerman, T., Balada-Llasat, J. M. & Pancholi, P. (2010). Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 54, 4678-4683.
29. Tan, T. Y., Ng, L. S. Y., Tan, E. & Huang, G. (2007). In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 60, 421-423.
30. Tripodi, M. F., Durante-Mangoni, E., Fortunato, R., Utili, R. & Zarrilli, R. (2007). Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases. Int J Antimicrob Agents 30, 537-540.
31. Vila-Farres, X., Garcia de la Maria, C, Lopez-Rojas, R., Pachón, J., Giralt, E. & Vila, J. (2011). In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii. Clin Microbiol Infect http:// dx.doi.org/10.1111/j.1469-0691.2011.03581.x (Epub ahead of print).